REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $814,608 | +91.7% | 5,123 | +219.0% | 0.01% | +14.3% |
Q4 2021 | $425,000 | +12.7% | 1,606 | +23.5% | 0.01% | +16.7% |
Q3 2021 | $377,000 | -59.2% | 1,300 | -72.7% | 0.01% | -68.4% |
Q1 2021 | $925,000 | -29.2% | 4,759 | -30.2% | 0.02% | -48.6% |
Q4 2020 | $1,307,000 | +91.9% | 6,822 | -3.2% | 0.04% | -39.3% |
Q1 2020 | $681,000 | -74.8% | 7,051 | -84.6% | 0.06% | -45.5% |
Q1 2019 | $2,702,000 | +133.5% | 45,742 | +108.4% | 0.11% | +387.0% |
Q4 2018 | $1,157,000 | +17.6% | 21,944 | -7.6% | 0.02% | -23.3% |
Q2 2017 | $984,000 | +167.4% | 23,752 | +76.7% | 0.03% | +275.0% |
Q2 2016 | $368,000 | +44.3% | 13,444 | +41.7% | 0.01% | +14.3% |
Q1 2016 | $255,000 | -29.6% | 9,490 | -25.9% | 0.01% | -30.0% |
Q4 2015 | $362,000 | +36.6% | 12,810 | +34.4% | 0.01% | +11.1% |
Q3 2015 | $265,000 | -14.2% | 9,531 | +27.1% | 0.01% | 0.0% |
Q2 2015 | $309,000 | +0.7% | 7,496 | -25.8% | 0.01% | -10.0% |
Q1 2015 | $307,000 | -3.2% | 10,096 | -59.0% | 0.01% | -23.1% |
Q1 2014 | $317,000 | – | 24,627 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |